chrisvoncsefalvay/vaers-outcomes huggingface dataset:
flu like symptoms; chills; dizziness; fever; night sweats; Initial information received on 12-Sep-2019 regarding an unsolicited valid non-serious case received from a other non health care professional (Pharmacy-Other).  This case involves a female patient who experienced night sweats (night sweats), flu like symptoms (influenza like illness), chills (chills), dizziness (dizziness), fever (pyrexia), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), and family history were not provided. It was reported that she has never had a reaction over the last 20 plus years of getting the flu shot.   On an unknown date, the patient received 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT6647MA, exp date: 30 June 2020 via unknown route in unknown administration site.  On an unknown date, the patient had night sweats (night sweats), flu like symptoms (influenza like illness), chills (chills), dizziness (dizziness), fever (pyrexia) in the evening same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Lab data was not reported.  Final diagnosis was fever, dizziness, chills, flu like symptoms and night sweats.   It was not reported if the patient received a corrective treatment.  The patient was recovered from all the events on an unspecified date.  List of document held by sender: none.
Information has been received from a consumer concerning her 11 year old daughter who on 31-OCT-2007 was vaccinated with the first dose and on 28-Dec-2007 with the second dose of GARDASIL (lot# not provided). The patient was scheduled to receive the third dose on 28-Mar-2008. On 29-Mar-2008, the patient experienced nose bleeds. Unknown medical attention was sought. The patient's outcome was unknown. No product quality complaint involved. Additional information has been requested.
Patient was positive for covid even after receiving both doses of vaccine; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Patient was positive for covid even after receiving both doses of vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient was positive for covid even after receiving both doses of vaccine). At the time of the report, COVID-19 (Patient was positive for covid even after receiving both doses of vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   In the end of January, Covid test was performed with positive results  No concomitant medication was reported.                   No treatment medication was reported.
a four year-old child was administered Menactra, rather than the intended MMR vaccine/no AE;Initial information regarding an unsolicited valid non-serious case was received from another health professional via medical information (Reference number- 00472867) and transmitted on 12-Feb-2021.   This case involves a 4 year old female who received a 0.5 mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] once, [injection, lot number: U6828AB, expiry date: 29-Jan-2022] via intramuscular route at right thigh on 28-Feb-2021 for prophylactic vaccination, rather than the intended MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE [MMR] [lot number, expiry date and other dosing details not applicable] (wrong product administered).   Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, HIB VACCINE CONJ (TET TOX), PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, POLIO VACCINE INACT 3V (MRC 5), TETANUS VACCINE TOXOID (PENTACEL), INFLUENZA VACCINE and HEPATITIS A VACCINE.  It was a case of actual medication error due to wrong vaccine administered.   No adverse effect had been reported after vaccination.   At the time of reporting it was reported that, the suspect was used first time.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Congestion, stuffy nose, store throat, things taste funny, fever x1 day, diarrhea    Cough -     benzonatate (TESSALON) 100 mg capsule; Take 1 capsule (100 mg total) by mouth 3 (three) times a day as needed  for cough for up to 7 days -     guaiFENesin (MUCINEX) 600 mg 12 hr tablet; Take 2 tablets (1,200 mg total) by mouth 2 (two) times a day as needed  for cough for up to 7 days
knee pain; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a 93-year-old female patient (mother) that A 93-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 04Feb2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that that the reporter's mother got the 1st dose on Covid-19 vaccine recently. her mother might need cortazone shot next week and wants to know if her mother can take tylenol for knee pain. Read the literature Gave the caller the number and transferred to (Name) in Faxing to for potential AE as not known if knee pain is worse or not after first vaccine. Outcome of the event was unknown.  Follow-up (05Feb2021): This is a follow-up spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a patient that:Her mother got her first covid vaccine shot yesterday and is scheduled to get her cortisone shot for her knee next week. Also will be taking Tylenol Wanted to know if these will interfere with the vaccine.  Information on the lot/batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
23 hours post vaccine developed fever, aches, nausea, headache 8 days post vaccine developed Bell?s Palsy (later diagnosed and seen on imaging)
Patients mother contacted the office on 05/02/2013 AM with patient's symptoms which included; low grade fever, swelling and redness at vaccination site (RT), nausea, vomiting, loss of appetite started end of day after date of vaccination 04/30/2013.
Employee reported positive to COVID-19 09/29/2021. requires that all breakthrough cases be submitted to VAERS reporting system.
Experienced extreme itchiness after vaccine and have since experienced constant hives and red bumps all over.  My hair is also falling out in extreme amounts. I have a 13 year old and a newborn. I delivered my son via c-section on November, 24 2022. He weighed 7lbs 12oz. I was required by my employer to get the vaccine.
Two weeks after second shot, developed shingles on right breast , under armpit and on to my back.
Entire arm became red; hot to the touch; Low grade fever; Aches; Fever; Chills; Whole arm turned black and blue; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Whole arm turned black and blue), PAIN (Aches), ERYTHEMA (Entire arm became red), FEELING HOT (hot to the touch) and PYREXIA (Fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced CONTUSION (Whole arm turned black and blue). On 21-Jan-2021, the patient experienced PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills). On 28-Jan-2021, the patient experienced ERYTHEMA (Entire arm became red), FEELING HOT (hot to the touch) and PYREXIA (Low grade fever). On 21-Jan-2021, CONTUSION (Whole arm turned black and blue) outcome was unknown, PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, ERYTHEMA (Entire arm became red) and FEELING HOT (hot to the touch) had not resolved and PYREXIA (Low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Concomitant product use was not provided  by the reporter.  Treatment information was not provided.
Pt. states that after receiving the 2nd dose of Phizer 08/03/2021, started the experience symptoms 08/04/2021 during the evening of muscle aches, flu-like symptoms, fatigue, chills, nausea, fever, and overall tiredness. Slowly subsiding over time but emotional interruptions (crying).  Follow-Up appt. planned.
5minutes after vaccination became flush w/rapid HR.  Denied C/O SOB, CP BP 188/108 reached 200/104  PR 68. 911 called arrived 11;17 BP 176/88 HR 64 No apparent distress. Flush feeling resided. Declines transfer to hospital-started lab a 1:00pm w/her MD today . Paramedics left @ 11:31AM . pt in not apparent distress
Headache in back of head and pain in neck.  Stiffness in the neck.  Fatigue.  Runny nose.  All symptoms are still continuing, but intermittent.
Pt has experienced extremely long and extremely heavy menstrual periods.  Her 1st shot was given on 6/2/21, same location, Lot # EW 0217.  Her first irregular period began in early July and lasted 3 weeks.  Then she had two weeks with a period before the current one started again.  This was has been going on for 9 weeks.  A doctor has finally prescribed a birth control pill to attempt to stop this current pill.
About 10 minutes post vaccination, patient started experiencing labored breathing, headache and slight chest pain.  Mother of patient also stated patient has history of anxiety.
2 days after immunization 103 fever, 5 days after immunizations hair started falling out.
No adverse effect were reported; patient was inadvertently administered an expired dose of VAQTA; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.     On 21-MAY-2019, the patient was vaccinated inadvertently with an expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # R009952, expiry date on 17-MAR-2019, by intramuscular route, for prophylaxis. No adverse effects were reported.
I experienced COVID-19 after my vaccine. My symptoms were a bad a very bad cough.  I took a home COVID-19 test on 08/24/2022. I had fatigued, stuffy nose and just general malaise.  I also had a sore arm and had a half a day of being tired.  I still have a bit of a cough from my COVID-19 symptoms.
Approximately 2 1/2 weeks after receiving my first dose of the Moderna vaccine, I woke up on January 16 in severe pain in my right shoulder and arm. Approximately two hours later I developed paralysis in my right fourth and fifth finger. I eventually saw a neurologist who diagnosed me as having Turner parsonage syndrome. The pain has resolved but I continued to have paralysis in my right fourth and fifth finger and the lateral portion of my right hand.
Information was received from a physician regarding a 13 year old female patient with an allergy to amoxicillin (hives). On 17-FEB-2015, the patient received a routine vaccination with her first dose of GARDASIL lot # K006960, 0.5 ml, intramuscularly in the left arm. "4 Days after" she received GARDASIL, the patient developed hives at her injection site. The patient also reported that "one month after she received GARDASIL," she became ill and developed hives on both of her legs and also at the injection site where she received GARDASIL. The patient did not report any of these adverse experiences to the physician until she came in or her second dose of GARDASIL. The patient did not receive her second dose of GARDASIL when she was scheduled to receive it because of her report of having developed hives. The outcome of the hives at her injection site, becoming ill and developing hives on both of her legs and also at the injection site were reported as recovered. No additional information was provided. Additional information has been requested.
This spontaneous report as received from a physician's office via field representative refers to unspecified number of patients of unknown age and demographics. Current conditions and medical history was not reported. On an unknown date, the patients were vaccinated with ZOSTAVAX lot number K000328, expiry date- 06-MAR-2015 (dose, route and frequency were not reported). Concomitant medications were not reported. It was reported that improperly stored ZOSTAVAX (7 doses) have been administered to patients. No adverse effects reported. Product quality complaint was not reported. Additional information has been requested.
Had blood and mucus in stool the day after he got the vaccines for 1 to 2 days, then resolved.  1 week after his 2 month vaccines which were Pentacel, Rotateq, Hep B, and Prevnar he had blood in his stool for 1 day. Both times he was not fussy and ate normal.
PAIN IN UPPER BODY/ARMS/SHOULDER THAT STARTED BETWEEN 01:00 AND 01;30 AM WEDNESDAY AND LASTED UNTIL 07:00AM OR SO.  TOOK IBUPROFEN WHICH HELPED TO SOME EXTENT.  PAIN WAS SIMILAR TO LACTIC ACID BUILDUP AFTER A HARD WORKOUT ONLY WAS WORSE.
This case was reported by a pharmacist and described the occurrence of leg weakness in a 63-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medical conditions included dizziness and sulfa allergy. Concurrent medications included Meclizine. On 27 October 2009 at 12:30 the subject received unspecified dose of FLULAVAL (.5 ml, unknown, right arm). On 27 October 2009, approximately 15 minutes after vaccination with FLULAVAL, the subject experienced leg weakness, walking difficulty and muscle cramp. At the time of reporting the outcome of the events was unknown. The pharmacist considered the events were possibly related to vaccination with FLULAVAL. On 27 October 2009, the pharmacist reported that another pharmacist injected a female subject with FLULAVAL. After approximately 15 minutes, the subject began to feel weak in the legs, had muscular cramping, and had difficulty walking. The subject went home and the husband planned to take her to an emergency room. At the time of reporting, the outcome was not known. It was reported that the subject received FLULAVAL at 12:30 and experienced the events at 13:00 (reported as approximately 15 minutes later). The subject consulted a health care professional regarding the event(s).
Vaccinating nurse gave client the incorrect vaccine for her age group . Client received pediatric Pfizer vaccine of 0.2 ml instead of the Pfizer +12  0.3 ml intended for her age group.  Mother and client were made aware of error and were given the appropriate teaching. Client was re-vaccinated with correct dose.
Noticed ten days after receiving second dose: 2" x10" red area, hive-like small bumps, slightly itchy. Entire area NOT raised.  May have been occurring regularly since vaccination, but I haven't taken visual notice. Itching noticeable when I get in a hot shower, am in the sun, and when I have hot flashes. Itching does not cause me to lose sleep or scratch with fingernails.  After talking with my 24/7 insurance nurse line, I will use hydrocortizone cream and ice.  Rejected suggestion of NSAID and antihystamine.  Have taken cell phone photo of affected area and traced outline on the skin, per nurse's suggestion.
Patient felt dizzy, got her water. Become non verbal hands shook eyes focused dilated and non responsive to movement head went back
Injection site pain, that did not have immediately after the shot, and it past already; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Injection site pain, that did not have immediately after the shot, and it past already) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient had no known allergies (medications, food, and other products). The patient never had COVID positive test or diagnosis. No history related to mentioned AE and both acute and chronic illnesses at the time of vaccination. No other vaccines given within one month prior to Moderna COVID-19 vaccine.  Previously administered products included for COVID-19 vaccination: PFIZER BIONTECH COVID-19 VACCINE (primary series with Pfizer (Dose 1)), PFIZER BIONTECH COVID-19 VACCINE (First booster with Pfizer) and PFIZER BIONTECH COVID-19 VACCINE (primary series with Pfizer (Dose 2)). Past adverse reactions to the above products included No adverse reaction with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 01-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2022, the patient experienced VACCINATION SITE PAIN (Injection site pain, that did not have immediately after the shot, and it past already). At the time of the report, VACCINATION SITE PAIN (Injection site pain, that did not have immediately after the shot, and it past already) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.  Moderna employee called to report that his mother in-law had an adverse event after receiving the second booster of the Moderna covid19 vaccine on the 01-May-2022. He stated that she had a primary series with Pfizer and the first booster with Pfizer, and that on the 08-May-2022 she had injection site pain, that did not have immediately after the shot, and it past already. The symptoms were improved. He gave consent to be follow by safety. Reported adverse event did not cause patient to seek medical care. The patient never experienced a similar event in the past.
accidentally received two doses of IPOL with no reported adverse event; Initial information received on 07-Oct-2022 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves a 5-year-old male patient who accidentally received two doses of IPV (VERO) [IPOL] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Prophylactic vaccination; VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Prophylactic vaccination; and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) for Prophylactic vaccination.  On 07-Oct-2022, the patient received 1ml total dose of suspect IPV (VERO) injection (strength: standard) (lot number: V1A121M and expiry date: 15-Feb-2024), in the upper arm laterality for Immunization and on the same day patient accidentally received two doses of ipol with no reported adverse event (extra dose administered).  It was reported, Physician requesting any available information regarding guidance or safety related concerns. This situation is reported as a medication error due to accidental administration of 2 IPOL doses to the patient on the same day. The initial administration on 07OCT2022 was the 4th dose in the series. No concerns or symptoms noted prior to the patient leaving the clinic.  Action taken with POLIOMYELITIS VACCINE (INACTIVATED) (IPOL) was not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient reported possible side effect with vaccine.  She noticed a large red swollen round spot on left bicep below where the shot was given . Patient took Alieve. It got a bit smaller today. Her head felt heavy the other day after getting the vaccine and she had to lie down at home. Patient has had flu and the first dose of shingles vaccines in the past without reaction but the only difference is that she both two vaccines in one day this time.  Recommended patient to apply ice and continue Alieve. If symptom gets worse, patient is to contact medical doctor.
Late second dose / received the first dose of Shingrix on 11/27/2019 and had not yet received the second dose of Shingrix; This case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 27th November 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine which led to incomplete course of vaccination. No further events were reported.  The reporter consented to follow up.
This case was reported by a consumer via sales rep and described the occurrence of fever in a adult female patient who received Shingrix for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced fever, influenza-like symptoms, chills, pain, injection site wheal, injection site warmth and injection site erythema. On an unknown date, the outcome of the fever, influenza-like symptoms, chills, pain, injection site wheal, injection site warmth and injection site erythema were unknown. It was unknown if the reporter considered the fever, influenza-like symptoms, chills, pain, injection site wheal, injection site warmth and injection site erythema to be related to Shingrix. Additional details were reported as follows: The age at vaccination was not reported. The patient received experienced flu-like symptoms (fever, chills, aches) within 8 to 12 hours of vaccination. On Day 3, the patient had a welt on arm near injection site was hot and red and lasted 1 day. The reporter did agree to be contacted for follow up information. This case has been linked with the case US2018GSK185204 with the 2nd dose received by same patient reported by the same reporter.
The patient's arm was very sore, swollen, red, and warm to the touch. Patient took some ADVIL to relieve the pain.